An interventional study of mechanical thrombectomy in Ischemic Stroke, sponsored by Abington Memorial Hospital. Suspended at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-08-02.
Sponsored by Abington Memorial Hospital · Not applicable, Interventional, and Treatment
A prospective pilot study to evaluate the recanalization and safety of mechanical thrombectomy through a cerebral angiogram in patients with stroke symptoms last seen normal between 8 - 24 hours.
Ischemic stroke patients who are 8-24 hrs from symptom onset without prior mechanical or IV thrombolytic treatment and are screen with CT or MR perfusion imaging showing penumbra and infarction not > 1/3rd the territory.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's planned enrollment of 25 is below the median of 50 across 5,369 interventional studies indexed under Stroke.
Browse Stroke studies →Abington Memorial Hospital is the lead sponsor of 9 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Mechanical thrombectomy with either Penumbra system, TREVO, or Solitaire device for acute stroke symptom onset between 8 - 24 hours
Device: mechanical thrombectomy
Mechanical thrombectomy by either Penumbra system, TREVO, or Solitaire retrieval device
Also known as: Penumbra system, TREVO, Solitaire
Thrombolysis in Cerebral Infarction (TICI) score
Time frame: 6 months
National Institutes of Health Stroke Scale (NIHSS) score
Time frame: 6 months
Montreal Cognitive Assessment (MoCA) tool
Time frame: 6 months
Modified Rankin Scale
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is suspended, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Abington Memorial Hospital